Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-01
2005-11-01
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S367000, C548S152000, C548S224000
Reexamination Certificate
active
06960607
ABSTRACT:
This invention provides estrogen receptor modulators of formula I, having the structurewhereinR1, R2, R3, and R4, and X as defined in the specification, or a pharmaceutically acceptable salt thereof.
REFERENCES:
Mendelsohn and Karas, “The protective effects of estrogen on the cardiovascular system,” New Engl. J. Med. (1999) 340:1801-1811.
Epperson, et al., “Gonadal steroids treatment of mood disorders,” Psychosomatic Med. (1999) 61:678-697.
Crandall, J. “Estrogen replacement therapy and colon cancer: a clinical review,” Women's Health Gender-Based Med. (1999) 8:1155-1166.
Monk and Brodaty, “Us of estrogens for the prevention and treatment of Alzheimer's disease,” Dementia & Geriatric Cognitive Disorders (2000) 11:1-10.
Hum and Macrae, “Estrogen as a neuroprotectant in stroke,” J. Cerebral Blood Flow & Metab. (2000) 20:631-652.
Calvin, “Oestrogens and wound healing,” Maturitas (2000) 34:195-200.
Finking , et al., “The effects of estrogen in the caridovascular system,” Zeitschrift fur Kardiolagie (2000) 89:442-453.
Brincat, “Hormone replacement therapy and the skin,” Maturitas (2000) 35:107-117.
Al-Azzawi, “The menopause and its treatment in perspective,” Postgrad. Med. J. (2001) 77:292-304.
Moggs ad Orpahanides, “Estrogen receptors: orchestrators of pietropic cellular response,” EMBO Reports (2001) 2:775-7781.
Hall, et al., “The multifaceted mechanisms of estradiol and estrogen receptor signaling,” J. Biol. Chem. (2001) 276:36869-36872.
McConnell, Principles of Molecular Regulation, (2000) pp. 351-361.
McKenna, et al., “Nuclear receptor coregulators: cellular and molecular biology,” Endocrine Rev. (1999) 20:321-344.
Quaedackers, et al., “4-Hydroxytamoxifen trans-represses nuclear factor kappa-B activity in human osteobastic U2-OS cells through estrogen receptor (ER)alpha and not through ERbeta,” Endocrinol. (2001) 142:1156-1166.
Bhat, et al., “A novel estrogen receptor beta: identification and functional analysis of additional N-terminal amino acids,” J. Steroid Biochem. Mol. Biol. (1998) 67:233-240.
Pelzer, et al., “Estrogen effects in the mycardim: inhibition of NF-kappaB DNA binding by estrogen recptor-alpha and -beta,” Biochem. Biophys. Res. Comm. (2001) 286:1153-1157.
Levin, “Cell localization, physiology, and non-genomic actions of estrogen receptors,” J. Appl. Physiol. (2001) 91:1860-1867.
Levin, “Cellular functions fo the plasma membrane estrogen receptor,” Trends Endocrinol. Metab. (1999) 10:374-377.
Green, et al., “Human oestrogen reseptor cDNA: sequence, expression and homology to v-erb-A,” Nature (1986) 320:134-139.
Kuiper, et al., “Cloning of a novel estrogen receptor expressed in ra prostate and ovary,” Proc. Natl. Acad. Sci. USA (1996) 93:5925-5930.
Couse, et al., “Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse,” endocrinol. (1997) 138:4613-4621.
Kuiper et al., “Comparison of the ligand binding specificaity and transcript tissue ditrubution of estrogen receptors alph and beta,” Endocrinol. (1997) 138:863-870.
Sar and Welsch, “Differential expression of estrogen receptor-beta and estrogen receptor -alpha in the rat ovary,” Endocrinol. (1999) 140:963-971.
Fitzpatrick, et al., “Expression of estrogen receptor-beta protein in rodent ovary,” Endocrinol. (1999) 140:2581-2591.
Cowley, et al., “Estrogen receptors alpha and beta form heterodimers on DNA,” J. Biol. Chem. (1997) 272:19858-19862.
McDonnell, J., “Selective estrogen receptor modulators (SERMs): a first step in the development of perfect hormone replacement therapy regimen,” Soc. Gynecolog. Invest. (2000) 7:S10-S15.
Goldstein, “A pharmacological review of selective oestrogen receptor modulators,” Human Reproduction Update (2000) 6:212-224.
Pike, et al., “Structure of the ligand-binding domain of oestrogen receptor beta presence of a partial agonist and a full antagonist,” EMBO J. (1999) 18:4608-4618.
Shiau, et al., “The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen,” Cell (1998) 95:927-937.
Ogawa, et al., “The complete primary structure of human estrogen receptor beta (hER-beta) and its heterodimerization with ER alpha in vivo and in vitro,” Biochem. Biophys. Res. Comm. (1998) 243:122-126.
Sun, et al., “Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta,” Endocrinol. (1999) 140:800-804.
Shugrue, et al., “Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: an in situ hybridization study,” Endocrinol. (1997) 138:5476-5484.
Dubai, et al., “Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury,” Proc. Natl. Acad. Sci. USA (2001) 98:1952-1957.
Lundeen, et al., “Rat urine complement C3 expression as a model for progesterone receptor modulators,”J. Steroid. Mol. Biol. (2001) 78:137-143.
Dubal, et al., “Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors,” J. Neurosci. (1999) 19:6385-6393.
Albert Leo M.
Gunawan Iwan
Harris Heather A.
Keith, Jr. James C.
Malamas Michael S.
Milowsky Arnold S.
O'Connor Zozen
Saeed Kamal A.
Straher Michael P.
Wyeth
LandOfFree
Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3512064